257 related articles for article (PubMed ID: 10526523)
1. Borrmann's type IV gastric cancer: clinicopathologic analysis.
Yokota T; Teshima S; Saito T; Kikuchi S; Kunii Y; Yamauchi H
Can J Surg; 1999 Oct; 42(5):371-6. PubMed ID: 10526523
[TBL] [Abstract][Full Text] [Related]
2. [Problems of surgical management of Borrmann's type IV stomach cancer--with special reference to subdivision of Borrmann's type IV].
Kito T
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2461-7. PubMed ID: 6651306
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
4. Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric resection.
Maehara Y; Moriguchi S; Orita H; Kakeji Y; Haraguchi M; Korenaga D; Sugimachi K
Surg Gynecol Obstet; 1992 Jul; 175(1):13-6. PubMed ID: 1621194
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of stage 1 gastric cancer: comparison of macroscopic and microscopic findings.
Baba H; Ohshiro T; Yamamoto M; Endo K; Adachi E; Kakeji Y; Kohnoe S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):554-8. PubMed ID: 9164536
[TBL] [Abstract][Full Text] [Related]
6. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
[TBL] [Abstract][Full Text] [Related]
7. [Surgical results of scirrhous carcinoma of the stomach].
Kito T; Yamamura Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1256-61. PubMed ID: 2837985
[TBL] [Abstract][Full Text] [Related]
8. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
9. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
11. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study of diffuse carcinoma of stomach (author's transl)].
Shimoda T
Hokkaido Igaku Zasshi; 1978 Nov; 52(6):305-25. PubMed ID: 204562
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.
An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S
Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of patients with Borrmann type IV gastric carcinoma.
Kitamura K; Beppu R; Anai H; Ikejiri K; Yakabe S; Sugimachi K; Saku M
J Surg Oncol; 1995 Feb; 58(2):112-7. PubMed ID: 7844980
[TBL] [Abstract][Full Text] [Related]
15. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics of gastric cancer patients with cancer infiltration at surgical margin at gastrectomy.
Fujimoto S; Takahashi M; Mutou T; Kobayashi K; Toyosawa T; Ohkubo H
Anticancer Res; 1997; 17(1B):689-94. PubMed ID: 9066603
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of gastric cancer tumours of less than 2 cm in diameter: rationale for limited surgery.
Yokota T; Kunii Y; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi H; Takahashi M; Kikuchi S; Yamauchi H
Eur J Surg Oncol; 2002 Apr; 28(3):209-13. PubMed ID: 11944951
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prognosis of para-aortic lymph node metastasis in gastric cancer.
Nakane Y; Okamura S; Masuya Y; Okumura S; Akehira K; Hioki K
Hepatogastroenterology; 1998; 45(23):1901-6. PubMed ID: 9840173
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
